Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.1B | 5.1B | 5.0B | 4.9B |
Cost of revenue | 3.4B | 3.3B | 3.3B | 3.2B |
Gross profit | 1.7B | 1.8B | 1.7B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 791M | 844M | 833M | 781M |
Other operating expenses | — | — | — | — |
Operating income | 791M | 800M | 771M | 737M |
Non operating interest income | ||||
Income | 30M | 28M | 31M | 30M |
Expense | 12M | 19M | 14M | 10M |
Other income expense | 63M | -69M | -40M | -29M |
Pretax income | 872M | 740M | 748M | 728M |
Tax provision | 213M | 199M | 170M | 165M |
Net income | 663M | 546M | 582M | 566M |
Basic EPS | 1.3 | 1.1 | 1.2 | 1.1 |
Diluted EPS | 1.3 | 1.1 | 1.2 | 1.1 |
Basic average shares | 494M | 495M | 496M | 497M |
Diluted average shares | 495M | 496M | 496M | 498M |
EBITDA | 956M | 969M | 936M | 899M |
Net income from continuing op. | 663M | 546M | 582M | 566M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |